Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Wolfgang Froestl

Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting With Targets Other Than Receptors or Enzymes. Disease-Modifying Drugs. Update 2014

Journal of Alzheimer's Disease

Clinical Psychology

English

Activation of the GABAB Receptor Prevents Nicotine-Induced Locomotor Stimulation in Mice

Frontiers in Psychiatry

English

Related publications

Treatment of Dementias: Current Approaches and Disease Modifying Drugs

Journal of Nihon University Medical Association

English

P2Y Purinergic Receptors: New Targets for Analgesic and Antimigraine Drugs

Biochemical Pharmacology

English

Lipid Profiles in Rheumatoid Arthritis Patients Treated With Disease-Modifying Antirheumatic Drugs

English

Disease Modifying Treatments and Symptomatic Drugs for Cognitive Impairment in Multiple Sclerosis: Where Do We Stand?

Multiple Sclerosis and Demyelinating Disorders

English

Patient Preferences in the Choice of Disease Modifying Anti-Rheumatic Drugs

Value in Health

Occupational Health

English

Metabolism of Drugs With Inhibition of Enzymes

Journal of Drug Metabolism & Toxicology

English

Nanoparticle System for the Local Delivery of Disease Modifying Osteoarthritic Drugs

Osteoarthritis and Cartilage

Sports Medicine

Biomedical Engineering

English

The Choice Of, and the Decision to Apply, Disease Modifying Drugs.

Annals of the Rheumatic Diseases

Molecular Biology

English

Persistence With Biological Disease-Modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs

Drugs - Real World Outcomes

English